Fmoc-Lys(Boc)-OH

• Category :

  Intermediates

• Synonyms :

  n-alpha-fmoc-nepsilon-boc-l-lysine;nalpha-(9-fluorenylmethoxycarbonyl)-nepsilon-(tert-butoxycarbonyl)-l-lysine;Fmoc-L-Lys(Boc)-OH;

• CAS NO :

  71989-26-9

• EC NO :

  276-256-4

• Molecular Formula :

  C₂₆H₃₂N₂O₆

• Molecular Weight :

  468.55

• Main Specifications :

  Assay(HPLC) ≥99.0%

• InChI :

  InChI=1/C26H32N2O6/c1-26(2,3)34-24(31)27-15-9-8-14-22(23(29)30)28-25(32)33-16-21-19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h4-7,10-13,21-22H,8-9,14-16H2,1-3H3,(H,27,31)(H,28,32)(H,29,30)

• Packing :

  It is used to prepare dimeric RGD peptide-paclitaxel conjugate as model for integrin-targeted drug delivery. It is also used to synthesize DOTA-conjugated multivalent cyclic-RGD peptide dendrimers for tumor targeting and imaging use.

• Product description :

  　　Specifications:

  　　AppearanceWhite or off-white power

  　　Specific Rotation-9.5°~ -14.5°(C=2,DMF)

  　　Melting Point120~131℃

  　　D-isomer≤0.2%

  　　Water ≤2.0%

  　　Loss on drying ≤0.5%

  　　Single impurity ≤0.2%

  　　Dipeptide≤0.1%

  　　L-Lys≤0.1%

  　　Fmoc-beta-Ala≤0.1%

  　　Assay(HPLC)≥99.0%

• Uses :

  It is used to prepare dimeric RGD peptide-paclitaxel conjugate as model for integrin-targeted drug delivery. It is also used to synthesize DOTA-conjugated multivalent cyclic-RGD peptide dendrimers for tumor targeting and imaging use.

• Molecular Structure :